Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma
Phase 1 Withdrawn
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
Phase 1 Withdrawn
CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL
Phase 1 Withdrawn
Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis
Phase 1 Withdrawn
Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial
Phase 1 Withdrawn
Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Phase 1 Withdrawn
PARIS
Phase 1 Withdrawn
Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases
Phase 1 Withdrawn
ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
Phase 1 Withdrawn
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
Phase 1 Withdrawn
Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
Phase 1 Withdrawn
Radiation Use During Vemurafenib Treatment
Phase 1 Withdrawn
Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.
Phase 1 Withdrawn
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery
Phase 1 Withdrawn
Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation
Phase 1 Withdrawn
Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma
Phase 1 Withdrawn
WAR
Phase 1 Withdrawn
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Phase 1 Withdrawn
Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer
Phase 1 Withdrawn
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
Phase 1 Withdrawn
Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)
Phase 1 Withdrawn
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer
Phase 1 Withdrawn